Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
SLC6A3 1件: SLC6A3 💬Alcoholism
|
Bupropion hydrochloride Bupropion hydrochloride 💬Alcoholism
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬1. Alcoholism
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
SLC6A3 1件: SLC6A3 💬Alcoholism
|
Bupropion Bupropion 💬Alcoholism
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬1. Alcoholism
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
SLC6A3 1件: SLC6A3 💬Alcoholism
|
Bupropion hydrobromide Bupropion hydrobromide 💬Alcoholism
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬1. Alcoholism
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
PTGS2 1件: PTGS2 💬Alzheimer disease
|
Celecoxib Celecoxib 💬Alzheimer disease
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬4. Alzheimer disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
SLC6A3 1件: SLC6A3 💬Amphetamine addiction
|
Bupropion hydrochloride Bupropion hydrochloride 💬Amphetamine addiction
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬5. Amphetamine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
SLC6A3 1件: SLC6A3 💬Amphetamine addiction
|
Bupropion Bupropion 💬Amphetamine addiction
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬5. Amphetamine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
SLC6A3 1件: SLC6A3 💬Amphetamine addiction
|
Bupropion hydrobromide Bupropion hydrobromide 💬Amphetamine addiction
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬5. Amphetamine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Arachidonic acid metabolism 💬 5 genes, 25 drugs (DrugBank) and 44 diseases |
PTGS2 1件: PTGS2 💬Arachidonic acid metabolism
|
Celecoxib Celecoxib 💬Arachidonic acid metabolism
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬8. Arachidonic acid metabolism
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
PTGS2 1件: PTGS2 💬C-type lectin receptor signaling pathway
|
Celecoxib Celecoxib 💬C-type lectin receptor signaling pathway
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬9. C-type lectin receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬cGMP-PKG signaling pathway
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬10. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬cGMP-PKG signaling pathway
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬10. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Chemical carcinogenesis - DNA adducts 💬 2 genes, 23 drugs (DrugBank) and 41 diseases |
PTGS2 1件: PTGS2 💬Chemical carcinogenesis - DNA adducts
|
Celecoxib Celecoxib 💬Chemical carcinogenesis - DNA adducts
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬12. Chemical carcinogenesis - DNA adducts
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
SLC6A3 1件: SLC6A3 💬Cocaine addiction
|
Bupropion hydrochloride Bupropion hydrochloride 💬Cocaine addiction
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬13. Cocaine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
SLC6A3 1件: SLC6A3 💬Cocaine addiction
|
Bupropion Bupropion 💬Cocaine addiction
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬13. Cocaine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
SLC6A3 1件: SLC6A3 💬Cocaine addiction
|
Bupropion hydrobromide Bupropion hydrobromide 💬Cocaine addiction
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬13. Cocaine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
SLC6A3 1件: SLC6A3 💬Dopaminergic synapse
|
Bupropion hydrochloride Bupropion hydrochloride 💬Dopaminergic synapse
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬16. Dopaminergic synapse
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
SLC6A3 1件: SLC6A3 💬Dopaminergic synapse
|
Bupropion Bupropion 💬Dopaminergic synapse
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬16. Dopaminergic synapse
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
SLC6A3 1件: SLC6A3 💬Dopaminergic synapse
|
Bupropion hydrobromide Bupropion hydrobromide 💬Dopaminergic synapse
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬16. Dopaminergic synapse
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Efferocytosis 💬 29 genes, 74 drugs (DrugBank) and 93 diseases |
PTGS2 1件: PTGS2 💬Efferocytosis
|
Celecoxib Celecoxib 💬Efferocytosis
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬19. Efferocytosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Hormone signaling
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬20. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Hormone signaling
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬20. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PTGS2 1件: PTGS2 💬Human cytomegalovirus infection
|
Celecoxib Celecoxib 💬Human cytomegalovirus infection
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬22. Human cytomegalovirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
PTGS2 1件: PTGS2 💬Human papillomavirus infection
|
Celecoxib Celecoxib 💬Human papillomavirus infection
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬23. Human papillomavirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | IL-17 signaling pathway 💬 20 genes, 61 drugs (DrugBank) and 86 diseases |
PTGS2 1件: PTGS2 💬IL-17 signaling pathway
|
Celecoxib Celecoxib 💬IL-17 signaling pathway
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬24. IL-17 signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
SNAP25 1件: SNAP25 💬Insulin secretion
|
Botulinum toxin type A Botulinum toxin type A 💬Insulin secretion
| Botulinum toxin type A | 002 14件: 2 , 5 , 6 , 7 , 13, 15, 17, 47, 51, 70, 113, 149, 171, 226 💬25. Insulin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
SNAP25 1件: SNAP25 💬Insulin secretion
|
Prabotulinumtoxin A Prabotulinumtoxin A 💬Insulin secretion
| Botulinum toxin type A | 002 14件: 2 , 5 , 6 , 7 , 13, 15, 17, 47, 51, 70, 113, 149, 171, 226 💬25. Insulin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
PTGS2 1件: PTGS2 💬Kaposi sarcoma-associated herpesvirus infection
|
Celecoxib Celecoxib 💬Kaposi sarcoma-associated herpesvirus infection
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬27. Kaposi sarcoma-associated herpesvirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Leishmaniasis 💬 40 genes, 68 drugs (DrugBank) and 102 diseases |
PTGS2 1件: PTGS2 💬Leishmaniasis
|
Celecoxib Celecoxib 💬Leishmaniasis
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬28. Leishmaniasis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
PTGS2 1件: PTGS2 💬MicroRNAs in cancer
|
Celecoxib Celecoxib 💬MicroRNAs in cancer
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬29. MicroRNAs in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Neuroactive ligand signaling
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬30. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Neuroactive ligand signaling
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬30. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
SLC6A2 2件: SLC6A2, SLC6A3 💬
|
Bupropion hydrochloride Bupropion hydrochloride 💬Neuroactive ligand signaling
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬32. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
SLC6A2 2件: SLC6A2, SLC6A3 💬
|
Bupropion Bupropion 💬Neuroactive ligand signaling
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬32. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
SLC6A2 2件: SLC6A2, SLC6A3 💬
|
Bupropion hydrobromide Bupropion hydrobromide 💬Neuroactive ligand signaling
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬32. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Neuroactive ligand-receptor interaction
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬35. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Neuroactive ligand-receptor interaction
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬35. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | NF-kappa B signaling pathway 💬 22 genes, 77 drugs (DrugBank) and 91 diseases |
PTGS2 1件: PTGS2 💬NF-kappa B signaling pathway
|
Celecoxib Celecoxib 💬NF-kappa B signaling pathway
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬37. NF-kappa B signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | Ovarian steroidogenesis 💬 7 genes, 34 drugs (DrugBank) and 53 diseases |
PTGS2 1件: PTGS2 💬Ovarian steroidogenesis
|
Celecoxib Celecoxib 💬Ovarian steroidogenesis
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬38. Ovarian steroidogenesis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
PTGS2 1件: PTGS2 💬Oxytocin signaling pathway
|
Celecoxib Celecoxib 💬Oxytocin signaling pathway
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬39. Oxytocin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
SLC6A3 1件: SLC6A3 💬Parkinson disease
|
Bupropion hydrochloride Bupropion hydrochloride 💬Parkinson disease
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬40. Parkinson disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
SLC6A3 1件: SLC6A3 💬Parkinson disease
|
Bupropion Bupropion 💬Parkinson disease
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬40. Parkinson disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
SLC6A3 1件: SLC6A3 💬Parkinson disease
|
Bupropion hydrobromide Bupropion hydrobromide 💬Parkinson disease
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬40. Parkinson disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
PTGS2 1件: PTGS2 💬Pathways in cancer
|
Celecoxib Celecoxib 💬Pathways in cancer
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬43. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
PTGS2 1件: PTGS2 💬Pathways of neurodegeneration - multiple diseases
|
Celecoxib Celecoxib 💬Pathways of neurodegeneration - multiple diseases
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬44. Pathways of neurodegeneration - multiple diseases
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
SLC6A3 1件: SLC6A3 💬Pathways of neurodegeneration - multiple diseases
|
Bupropion hydrochloride Bupropion hydrochloride 💬Pathways of neurodegeneration - multiple diseases
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬45. Pathways of neurodegeneration - multiple diseases
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
SLC6A3 1件: SLC6A3 💬Pathways of neurodegeneration - multiple diseases
|
Bupropion Bupropion 💬Pathways of neurodegeneration - multiple diseases
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬45. Pathways of neurodegeneration - multiple diseases
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
SLC6A3 1件: SLC6A3 💬Pathways of neurodegeneration - multiple diseases
|
Bupropion hydrobromide Bupropion hydrobromide 💬Pathways of neurodegeneration - multiple diseases
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬45. Pathways of neurodegeneration - multiple diseases
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 79 diseases |
PTGS2 1件: PTGS2 💬Regulation of lipolysis in adipocytes
|
Celecoxib Celecoxib 💬Regulation of lipolysis in adipocytes
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬48. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | Retrograde endocannabinoid signaling 💬 34 genes, 65 drugs (DrugBank) and 68 diseases |
PTGS2 1件: PTGS2 💬Retrograde endocannabinoid signaling
|
Celecoxib Celecoxib 💬Retrograde endocannabinoid signaling
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬49. Retrograde endocannabinoid signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
PTGS2 1件: PTGS2 💬Serotonergic synapse
|
Celecoxib Celecoxib 💬Serotonergic synapse
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬50. Serotonergic synapse
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | Small cell lung cancer 💬 16 genes, 43 drugs (DrugBank) and 64 diseases |
PTGS2 1件: PTGS2 💬Small cell lung cancer
|
Celecoxib Celecoxib 💬Small cell lung cancer
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬51. Small cell lung cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SLC6A2 2件: SLC6A2, SLC6A3 💬
|
Bupropion hydrochloride Bupropion hydrochloride 💬Synaptic vesicle cycle
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬52. Synaptic vesicle cycle
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SLC6A2 2件: SLC6A2, SLC6A3 💬
|
Bupropion Bupropion 💬Synaptic vesicle cycle
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬52. Synaptic vesicle cycle
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SLC6A2 2件: SLC6A2, SLC6A3 💬
|
Bupropion hydrobromide Bupropion hydrobromide 💬Synaptic vesicle cycle
| Bupropion | 008 6件: 8 , 18, 21, 96, 97, 171 💬52. Synaptic vesicle cycle
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SNAP25 1件: SNAP25 💬Synaptic vesicle cycle
|
Botulinum toxin type A Botulinum toxin type A 💬Synaptic vesicle cycle
| Botulinum toxin type A | 002 14件: 2 , 5 , 6 , 7 , 13, 15, 17, 47, 51, 70, 113, 149, 171, 226 💬55. Synaptic vesicle cycle
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SNAP25 1件: SNAP25 💬Synaptic vesicle cycle
|
Prabotulinumtoxin A Prabotulinumtoxin A 💬Synaptic vesicle cycle
| Botulinum toxin type A | 002 14件: 2 , 5 , 6 , 7 , 13, 15, 17, 47, 51, 70, 113, 149, 171, 226 💬55. Synaptic vesicle cycle
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | TNF signaling pathway 💬 23 genes, 61 drugs (DrugBank) and 90 diseases |
PTGS2 1件: PTGS2 💬TNF signaling pathway
|
Celecoxib Celecoxib 💬TNF signaling pathway
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬57. TNF signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | VEGF signaling pathway 💬 23 genes, 56 drugs (DrugBank) and 94 diseases |
PTGS2 1件: PTGS2 💬VEGF signaling pathway
|
Celecoxib Celecoxib 💬VEGF signaling pathway
| Celecoxib | 002 14件: 2 , 3 , 6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬58. VEGF signaling pathway
|
Alcoholism
29 genes, 81 drugs (DrugBank) and 60 diseases
Alzheimer disease
59 genes, 132 drugs (DrugBank) and 129 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
Arachidonic acid metabolism
5 genes, 25 drugs (DrugBank) and 44 diseases
C-type lectin receptor signaling pathway
27 genes, 66 drugs (DrugBank) and 102 diseases
cGMP-PKG signaling pathway
49 genes, 132 drugs (DrugBank) and 124 diseases
Chemical carcinogenesis - DNA adducts
2 genes, 23 drugs (DrugBank) and 41 diseases
Cocaine addiction
15 genes, 66 drugs (DrugBank) and 54 diseases
Dopaminergic synapse
31 genes, 102 drugs (DrugBank) and 104 diseases
Efferocytosis
29 genes, 74 drugs (DrugBank) and 93 diseases
Hormone signaling
66 genes, 211 drugs (DrugBank) and 153 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human papillomavirus infection
51 genes, 106 drugs (DrugBank) and 115 diseases
IL-17 signaling pathway
20 genes, 61 drugs (DrugBank) and 86 diseases
Insulin secretion
15 genes, 48 drugs (DrugBank) and 51 diseases
Kaposi sarcoma-associated herpesvirus infection
60 genes, 94 drugs (DrugBank) and 118 diseases
Leishmaniasis
40 genes, 68 drugs (DrugBank) and 102 diseases
MicroRNAs in cancer
33 genes, 75 drugs (DrugBank) and 90 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 117 diseases
Neuroactive ligand-receptor interaction
158 genes, 364 drugs (DrugBank) and 173 diseases
NF-kappa B signaling pathway
22 genes, 77 drugs (DrugBank) and 91 diseases
Ovarian steroidogenesis
7 genes, 34 drugs (DrugBank) and 53 diseases
Oxytocin signaling pathway
35 genes, 80 drugs (DrugBank) and 110 diseases
Parkinson disease
24 genes, 76 drugs (DrugBank) and 68 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Pathways of neurodegeneration - multiple diseases
63 genes, 138 drugs (DrugBank) and 132 diseases
Regulation of lipolysis in adipocytes
13 genes, 71 drugs (DrugBank) and 79 diseases
Retrograde endocannabinoid signaling
34 genes, 65 drugs (DrugBank) and 68 diseases
Serotonergic synapse
39 genes, 122 drugs (DrugBank) and 83 diseases
Small cell lung cancer
16 genes, 43 drugs (DrugBank) and 64 diseases
Synaptic vesicle cycle
8 genes, 34 drugs (DrugBank) and 42 diseases
TNF signaling pathway
23 genes, 61 drugs (DrugBank) and 90 diseases
VEGF signaling pathway
23 genes, 56 drugs (DrugBank) and 94 diseases
